UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Athletes with arrhythmias: Treatment and returning to athletic participation

Authors
Mark S Link, MD
Antonio Pelliccia, MD
Section Editors
Scott Manaker, MD, PhD
Peter J Zimetbaum, MD
Deputy Editor
Brian C Downey, MD, FACC

INTRODUCTION

As with the population in general, arrhythmias are not infrequently documented in athletes and can result in significant symptoms and impaired athletic performance. Rarely are arrhythmias fatal; however, sudden cardiac death (SCD) resulting from a malignant ventricular tachyarrhythmia is a devastating event in young and apparently healthy persons.

This topic will discuss the treatment of arrhythmias in athletes, along with the discussion of returning to competition/participation. The clinical manifestations and diagnostic evaluation of athletes with specific arrhythmias or arrhythmia-related syndromes are discussed in detail separately. Additionally, the risk of sudden death in athletes and the approach to screening to prevent sudden death in athletes are discussed elsewhere. (See "Athletes with arrhythmias: Clinical manifestations and diagnostic evaluation" and "Risk of sudden cardiac death in athletes" and "Electrocardiographic abnormalities and conduction disturbances in athletes" and "Screening to prevent sudden cardiac death in athletes".)

SYNCOPE

Syncope that occurs during exertion suggests a potentially life-threatening arrhythmic etiology (eg, aortic stenosis, hypertrophic cardiomyopathy, ventricular arrhythmia, etc) and should be evaluated urgently. On the other hand, syncope occurring after exertion (eg, during cooling off period) is more likely reflex in origin, similar to the vasovagal faint. Therapies to prevent recurrent syncope in athletes are highly variable depending upon the suspected etiology of the syncope. The diagnostic approach and management of syncope in athletes is similar to that in non-athletes and is discussed in detail separately. (See "Syncope in adults: Clinical manifestations and diagnostic evaluation" and "Syncope in adults: Management".)

Athletes with concerning syncope should have a full evaluation to ascertain the presence of underlying cardiac disease responsible for the syncope. Return to sport is permitted after the cause has been determined and, if necessary, treated. When any underlying cardiac disease has been reasonably excluded, the athlete can safely return to sport without restriction [1]. However, athletes with syncope or presyncope with a high risk of recurrence should not participate in sports where the likelihood of even a momentary loss of consciousness may be hazardous and/or potentially responsible for adverse events (such as scuba diving, climbing rocks, car racing, etc).

AV CONDUCTION ABNORMALITIES

Altered atrioventricular (AV) nodal conduction (eg, first degree AV block and Mobitz type I second degree AV block) can result from increased vagal tone, which is normally seen as an adaptive response to certain types of athletic conditioning, particularly endurance training (table 1). No specific limitations are necessary in this setting as long as the athlete is asymptomatic and the conduction abnormalities improve (ie, disappear) with exertion. However, higher degrees of AV conduction abnormality will require attention prior to participation in athletics.

                      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2017. | This topic last updated: Jun 29, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66:2412.
  2. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:1422.
  3. Kim JH, Noseworthy PA, McCarty D, et al. Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol 2011; 107:1083.
  4. Talan DA, Bauernfeind RA, Ashley WW, et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 1982; 82:19.
  5. Abdon NJ, Landin K, Johansson BW. Athlete's bradycardia as an embolising disorder? Symptomatic arrhythmias in patients aged less than 50 years. Br Heart J 1984; 52:660.
  6. Stein R, Medeiros CM, Rosito GA, et al. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J Am Coll Cardiol 2002; 39:1033.
  7. Bjørnstad H, Storstein L, Meen HD, Hals O. Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects. Cardiology 1994; 84:42.
  8. Wang YG, Mariman RJ, Wilbur DJ, et al. Various electrocardiographic and electrophysiologic presentations of normal and abnormal sinus node. J Cardiovasc Electrophysiol 1992; 3:187.
  9. Pediatric and Congenital Electrophysiology Society (PACES), Heart Rhythm Society (HRS), American College of Cardiology Foundation (ACCF), et al. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 2012; 9:1006.